| Primary |
| Bipolar Disorder |
10.3% |
| Depression |
10.3% |
| Schizophrenia |
10.3% |
| Psychotic Disorder |
7.7% |
| Schizoaffective Disorder |
7.7% |
| Schizophrenia, Paranoid Type |
7.7% |
| Anxiety |
5.1% |
| Insomnia |
5.1% |
| Orthostatic Hypotension |
5.1% |
| Vomiting |
5.1% |
| Affective Disorder |
2.6% |
| Blood Cholesterol |
2.6% |
| Confusional State |
2.6% |
| Dementia |
2.6% |
| Major Depression |
2.6% |
| Mental Disorder |
2.6% |
| Nausea |
2.6% |
| Sleep Disorder |
2.6% |
| Thinking Abnormal |
2.6% |
| Thyroid Disorder |
2.6% |
|
| Dystonia |
14.8% |
| Tardive Dyskinesia |
11.1% |
| Pharmaceutical Product Complaint |
7.4% |
| Serotonin Syndrome |
7.4% |
| Anaphylactoid Reaction |
3.7% |
| Catatonia |
3.7% |
| Chest Discomfort |
3.7% |
| Dark Circles Under Eyes |
3.7% |
| Electrocardiogram Qt Prolonged |
3.7% |
| Extrapyramidal Disorder |
3.7% |
| Fall |
3.7% |
| Hepatic Enzyme Increased |
3.7% |
| Ill-defined Disorder |
3.7% |
| Lip Swelling |
3.7% |
| Medication Error |
3.7% |
| Mental Status Changes |
3.7% |
| Musculoskeletal Discomfort |
3.7% |
| Negative Thoughts |
3.7% |
| Neutropenia |
3.7% |
| Pain |
3.7% |
|
| Secondary |
| Product Used For Unknown Indication |
28.8% |
| Drug Use For Unknown Indication |
20.3% |
| Schizophrenia |
6.0% |
| Depression |
5.8% |
| Psychotic Disorder |
5.8% |
| Agitation |
5.6% |
| Prophylaxis |
5.0% |
| Bipolar Disorder |
3.7% |
| Insomnia |
3.5% |
| Mania |
2.4% |
| Extrapyramidal Disorder |
1.9% |
| Mental Disorder |
1.7% |
| Foetal Exposure During Pregnancy |
1.5% |
| Gastric Cancer |
1.5% |
| Hepatitis C |
1.2% |
| Constipation |
1.1% |
| Major Depression |
1.1% |
| Suicide Attempt |
1.1% |
| Delusion |
1.0% |
| Hallucination |
1.0% |
|
| Completed Suicide |
16.1% |
| Ileus Paralytic |
14.3% |
| Urinary Incontinence |
8.0% |
| Cardiac Arrest |
6.3% |
| Death |
6.3% |
| Toxicity To Various Agents |
6.3% |
| Urinary Tract Infection |
6.3% |
| Vomiting |
4.5% |
| Hallucination, Visual |
3.6% |
| Pleurothotonus |
3.6% |
| Weight Increased |
3.6% |
| Fall |
2.7% |
| Physical Assault |
2.7% |
| Poisoning |
2.7% |
| Psychotic Disorder |
2.7% |
| Somnolence |
2.7% |
| Torticollis |
2.7% |
| Drug Toxicity |
1.8% |
| Epilepsy |
1.8% |
| Fatigue |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.1% |
| Schizophrenia |
14.1% |
| Bipolar Disorder |
8.3% |
| Depression |
7.6% |
| Pain |
6.9% |
| Drug Use For Unknown Indication |
3.4% |
| Anxiety |
3.3% |
| Insomnia |
3.2% |
| Hypertension |
2.8% |
| Schizoaffective Disorder |
2.7% |
| Hepatitis C |
2.4% |
| Psychotic Disorder |
2.4% |
| Asthma |
2.3% |
| Diabetes Mellitus |
1.9% |
| Metastases To Bone |
1.9% |
| Bipolar I Disorder |
1.6% |
| Smoking Cessation Therapy |
1.6% |
| Psoriasis |
1.5% |
| Mental Disorder |
1.4% |
| Sleep Disorder |
1.4% |
|
| Weight Increased |
14.6% |
| Type 2 Diabetes Mellitus |
9.2% |
| Schizophrenia |
6.9% |
| Pain |
5.4% |
| Vomiting |
5.4% |
| Granulocytopenia |
4.6% |
| Pancreatitis |
4.6% |
| Somnolence |
4.6% |
| Wheelchair User |
4.6% |
| White Blood Cell Count Increased |
4.6% |
| Diabetes Mellitus |
3.8% |
| Myocardial Infarction |
3.8% |
| Tremor |
3.8% |
| Vision Blurred |
3.8% |
| Weight Decreased |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Completed Suicide |
3.1% |
| Death |
3.1% |
| Drug Ineffective |
3.1% |
| Hyperammonaemic Encephalopathy |
3.1% |
|
| Interacting |
| Bipolar Disorder |
59.8% |
| Schizoaffective Disorder Bipolar Type |
11.2% |
| Product Used For Unknown Indication |
4.7% |
| Bipolar I Disorder |
3.7% |
| Psychotic Disorder |
3.7% |
| Gastric Cancer |
2.8% |
| Schizophrenia |
2.8% |
| Convulsion Prophylaxis |
1.9% |
| Hiv Infection |
1.9% |
| Onychomycosis |
1.9% |
| Parkinsonism |
1.9% |
| Schizoaffective Disorder |
1.9% |
| Extrapyramidal Disorder |
0.9% |
| Ill-defined Disorder |
0.9% |
|
| Tremor |
30.8% |
| Extrapyramidal Disorder |
15.4% |
| Urinary Tract Infection |
15.4% |
| Drug Interaction |
7.7% |
| Hallucination, Visual |
7.7% |
| Insomnia |
7.7% |
| Priapism |
7.7% |
| Visual Impairment |
7.7% |
|
